Genedx Holdings Corp Stock Fundamentals
| WGS Stock | 80.46 1.75 2.22% |
GeneDx Holdings Corp fundamentals help investors to digest information that contributes to GeneDx Holdings' financial success or failures. It also enables traders to predict the movement of GeneDx Stock. The fundamental analysis module provides a way to measure GeneDx Holdings' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to GeneDx Holdings stock.
At this time, GeneDx Holdings' Cost Of Revenue is comparatively stable compared to the past year. Total Operating Expenses is likely to gain to about 317.6 M in 2024, whereas Depreciation And Amortization is likely to drop slightly above 30.9 M in 2024. GeneDx | Select Account or Indicator |
GeneDx Holdings Corp Company Shares Outstanding Analysis
GeneDx Holdings' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current GeneDx Holdings Shares Outstanding | 27.47 M |
Most of GeneDx Holdings' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, GeneDx Holdings Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
GeneDx Shares Outstanding Historical Pattern
Today, most investors in GeneDx Holdings Stock are looking for potential investment opportunities by analyzing not only static indicators but also various GeneDx Holdings' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's shares outstanding growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of GeneDx Holdings shares outstanding as a starting point in their analysis.
GeneDx Holdings Shares Outstanding |
| Timeline |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
GeneDx Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
Based on the latest financial disclosure, GeneDx Holdings Corp has 27.47 M of shares currently outstending. This is 84.78% lower than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The shares outstanding for all United States stocks is 95.2% higher than that of the company.
GeneDx Holdings Corp Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining GeneDx Holdings's current stock value. Our valuation model uses many indicators to compare GeneDx Holdings value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across GeneDx Holdings competition to find correlations between indicators driving GeneDx Holdings's intrinsic value. More Info.GeneDx Holdings Corp is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, GeneDx Holdings' Return On Equity is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value GeneDx Holdings by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.GeneDx Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses GeneDx Holdings' direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of GeneDx Holdings could also be used in its relative valuation, which is a method of valuing GeneDx Holdings by comparing valuation metrics of similar companies.GeneDx Holdings is currently under evaluation in shares outstanding category among its peers.
GeneDx Holdings ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, GeneDx Holdings' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to GeneDx Holdings' managers, analysts, and investors.Environmental | Governance | Social |
GeneDx Fundamentals
| Return On Equity | -0.36 | ||||
| Return On Asset | -0.0827 | ||||
| Profit Margin | (0.31) % | ||||
| Operating Margin | (0.10) % | ||||
| Current Valuation | 2.16 B | ||||
| Shares Outstanding | 27.47 M | ||||
| Shares Owned By Insiders | 18.20 % | ||||
| Shares Owned By Institutions | 70.24 % | ||||
| Number Of Shares Shorted | 2.6 M | ||||
| Price To Book | 10.57 X | ||||
| Price To Sales | 8.09 X | ||||
| Revenue | 202.57 M | ||||
| Gross Profit | (26.75 M) | ||||
| EBITDA | (136.46 M) | ||||
| Net Income | (175.77 M) | ||||
| Total Debt | 119.77 M | ||||
| Book Value Per Share | 7.45 X | ||||
| Cash Flow From Operations | (180.15 M) | ||||
| Short Ratio | 3.56 X | ||||
| Earnings Per Share | (3.09) X | ||||
| Target Price | 80.83 | ||||
| Number Of Employees | 1 K | ||||
| Beta | 2.18 | ||||
| Market Capitalization | 2.16 B | ||||
| Total Asset | 473.67 M | ||||
| Retained Earnings | (1.3 B) | ||||
| Working Capital | 123.52 M | ||||
| Net Asset | 473.67 M |
About GeneDx Holdings Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze GeneDx Holdings Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of GeneDx Holdings using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of GeneDx Holdings Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 36 K | 34.2 K | |
| Total Revenue | 202.6 M | 225.5 M | |
| Cost Of Revenue | 141.9 M | 202.6 M | |
| Sales General And Administrative To Revenue | 0.66 | 0.51 | |
| Research And Ddevelopement To Revenue | 0.29 | 0.28 | |
| Capex To Revenue | 0.03 | 0.03 | |
| Revenue Per Share | 8.33 | 7.92 | |
| Ebit Per Revenue | (0.81) | (0.85) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for GeneDx Stock Analysis
When running GeneDx Holdings' price analysis, check to measure GeneDx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneDx Holdings is operating at the current time. Most of GeneDx Holdings' value examination focuses on studying past and present price action to predict the probability of GeneDx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneDx Holdings' price. Additionally, you may evaluate how the addition of GeneDx Holdings to your portfolios can decrease your overall portfolio volatility.